Morgan Stanley Reaffirms "Overweight" Rating for Pharvaris (NASDAQ:PHVS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Pharvaris (NASDAQ:PHVS – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Morgan Stanley in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $34.00 price target on the stock. Morgan Stanley’s price objective indicates a potential upside of 64.65% from the stock’s previous […]
Morgan Stanley Trims Pharvaris (NASDAQ:PHVS) Target Price to $34.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $5.61 and last traded at $5.67, with a volume of 81890 shares changing hands. The stock had previously closed at $5.95. Wall Street Analysts Forecast Growth A number of research analysts have […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Investment analysts at HC Wainwright upped their Q1 2024 EPS estimates for Elevation Oncology in a research report issued to clients and investors on Thursday, March 7th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.20) per share for the quarter, up from […]